Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹18 Cr₹60 Cr₹58 Cr₹46 Cr₹58 Cr

What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?

The latest Total Non-Current Liabilities ratio of VENUS REMEDIES is ₹18 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹18 Cr
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹46 Cr
Mar2021₹58 Cr

How is Total Non-Current Liabilities of VENUS REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹18 Cr
-69.12
Mar2024 ₹60 Cr
2.89
Mar2023 ₹58 Cr
26.60
Mar2022 ₹46 Cr
-20.94
Mar2021 ₹58 Cr -

Compare Total Non-Current Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,895.1 Cr 21.5% 46% 235.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,469.0 Cr -2.8% -1% 6.7% Stock Analytics
DIVIS LABORATORIES ₹173,305.0 Cr -3.3% 0.4% -2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,014.0 Cr -3.1% 2.9% 36.9% Stock Analytics
CIPLA ₹111,388.0 Cr -2.7% 5.3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,381.0 Cr -4.1% -3.7% 3.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

21.5%

46%

235.2%

SENSEX

-2.4%

-3.7%

-9.2%


You may also like the below Video Courses